Status:
UNKNOWN
ESM Versus OM ：A Randomized Controlled Trial
Lead Sponsor:
Beijing Friendship Hospital
Conditions:
Endoscopic Subcutaneous Mastectomy
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
The consideration of quality of life issues has led to the development of alternative surgeries for breast cancer patients, particularly in the case of localized disease. Nipple-sparing subcutaneous m...
Eligibility Criteria
Inclusion
- Diagnosis of stages I or II ductal carcinoma
- The distance from the tumor to the edge of the papilla is more than 3cm, the tumor volume is less than 3cm, the axillary lymph nodes have no obvious fusion and no adhesion with the axillary vein and brachial plexus
- Age from 18\~70
- ECOG scores 0\~2
- Normal function of liver, kidney and bone marrow
Exclusion
- Through physical examination and MRI, it was confirmed that the tumor did not invade the skin, but was confined to the gland and did not invade the surface of the gland.
- There are serious medical diseases
- Pregnant or lactating women women of childbearing age -
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
287 Patients enrolled
Trial Details
Trial ID
NCT04461847
Start Date
December 1 2020
End Date
December 31 2022
Last Update
December 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Friendship Hospital
Beijing, Beijing Municipality, China, 100050